Biotech Funds and FDA Actions Validate ACAD To Be Blockbuster. (post )
Just Read Article , Great For People New bto ACAD.
Acadia Has A Silver Lining In Its Playbook Seeking Alpha
Jun 5 2013,
In short, Acadia Pharmaceuticals is showing great promise in its pimavanserin trials. And, biotech fund
manager activity and FDA actions are validating my theory that pimavanserin is going to be a blockbusterdrug.